Literature DB >> 6362555

Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome delivery.

M Stevenson, A J Baillie, R M Richards.   

Abstract

Streptomycin and chloramphenicol were entrapped within large neutral or anionic unilamellar vesicles of egg phosphatidylcholine prepared by an ether injection method. Both antibiotics in liposomal form were inactive against Escherichia coli in a simple tube dilution assay. A comparison was made of the activities of the free and liposomal forms of the antibiotics against E. coli located within the macrophages of the J774.2 murine cell line. The apparent intracellular antibacterial activity of both antibiotics was increased more than 10-fold by entrapment in neutral liposomes and in the case of chloramphenicol in anionic liposomes containing phosphatidylserine. Anionic liposomes containing phosphatidic acid were much less effective carriers than neutral liposomes for either antibiotic in this in vitro system. Incubation at 4 degrees C of cells with liposomes containing antibiotic or carboxyfluorescein inhibited intracellular antibacterial activity and cell-associated fluorescence. The high intracellular activity of the liposomal antibiotics is consistent with their phagocytic uptake by the macrophages followed by intracellular liposomal degradation and antibiotic release. Liposomal modification of cellular uptake and intracellular distribution of antibiotics may be used to extend the activity of existing and new agents against intracellular infection of the reticuloendothelial system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6362555      PMCID: PMC185936          DOI: 10.1128/AAC.24.5.742

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line.

Authors:  P Ralph; I Nakoinz
Journal:  Nature       Date:  1975-10-02       Impact factor: 49.962

2.  Large volume liposomes by an ether vaporization method.

Authors:  D Deamer; A D Bangham
Journal:  Biochim Biophys Acta       Date:  1976-09-07

3.  Penetration of antimicrobials into tissue culture cells and leucocytes.

Authors:  K N Brown; A Percival
Journal:  Scand J Infect Dis Suppl       Date:  1978

4.  Liposome-cell interaction: transfer and intracellular release of a trapped fluorescent marker.

Authors:  J N Weinstein; S Yoshikami; P Henkart; R Blumenthal; W A Hagins
Journal:  Science       Date:  1977-02-04       Impact factor: 47.728

5.  The enhancement of neomycin activity on Escherichia coli by entrapment in liposomes [proceedings].

Authors:  N A Hodges; R Mounajed; C J Olliff; J M Padfield
Journal:  J Pharm Pharmacol       Date:  1979-12       Impact factor: 3.765

6.  Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug.

Authors:  C R Alving; E A Steck; W L Hanson; P S Loizeaux; W L Chapman; V B Waits
Journal:  Life Sci       Date:  1978-03       Impact factor: 5.037

7.  Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes.

Authors:  P F Bonventre; G Gregoriandis
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.

Authors:  P Ralph; J Prichard; M Cohn
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

9.  Antibody-mediated targeting of liposomes. Binding to lymphocytes does not ensure incorporation of vesicle contents into the cells.

Authors:  J N Weinstein; R Blumenthal; S O Sharrow; P A Henkart
Journal:  Biochim Biophys Acta       Date:  1978-05-18

10.  Suppressive activity of streptomycin on the growth of Mycobacterium lepraemurium in macrophage cultures.

Authors:  Y T Chang
Journal:  Appl Microbiol       Date:  1969-05
View more
  17 in total

1.  Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation.

Authors:  R Gomez-Flores; R Hsia; R Tamez-Guerra; R T Mehta
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 3.  Liposomes as drug delivery system in the treatment of infectious diseases. Potential applications and clinical experience.

Authors:  A Coune
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

Review 4.  Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.

Authors:  I A Bakker-Woudenberg; A F Lokerse; M T ten Kate; P M Melissen; W van Vianen; E W van Etten
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

5.  Unilamellar liposomes modulate secretion of tumor necrosis factor by lipopolysaccharide-stimulated macrophages.

Authors:  G F Brisseau; A Kresta; D Schouten; J M Bohnen; P N Shek; E Fok; O D Rotstein
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

Review 6.  Liposomes and nanoparticles in the treatment of intracellular bacterial infections.

Authors:  P Couvreur; E Fattal; A Andremont
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

7.  Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.

Authors:  R T Mehta
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 8.  Liposomes in treatment of infectious diseases.

Authors:  F Emmen; G Storm
Journal:  Pharm Weekbl Sci       Date:  1987-06-19

9.  Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink
Journal:  Infection       Date:  1988       Impact factor: 3.553

10.  Enhanced liposome-mediated activity of piperacillin against staphylococci.

Authors:  M C Nacucchio; M J Bellora; D O Sordelli; M D'Aquino
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.